Advanced Therapeutic Dressings for Effective Wound Healing - A Review

Journal of Pharmaceutical Sciences

Volumn 104, Issue 11, 2015, Pages 3653-3680

  Boateng, Joshua ^a   Catanzano, Ovidio ^a  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

Author keywords

macromolecular drug delivery; natural products; polymeric biomaterials; tissue engineering; wound healing

Indexed keywords

ANTIBIOTIC AGENT; BECAPLERMIN; BIGUANIDE; CALCIUM ALGINATE; CHLORHEXIDINE; GROWTH FACTOR; HYALURONIC ACID; HYDROGEN PEROXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEIC ACID; PLANT EXTRACT; POLY(HEXAMETHYLENE) BIGUANIDE HYDROCHLORIDE; POLYCAPROLACTONE; POLYMER; PROPOLIS; SILVER DERIVATIVE; UNCLASSIFIED DRUG; BIOMATERIAL;

ALOE VERA; AMPUTATION; BIOLOGICAL DRESSING; BURN; CHRONIC WOUND; DECUBITUS; DIABETIC FOOT; ELECTROSTIMULATION; FOAM; FOAM DRESSING; HONEY; HUMAN; HYDROGEL; HYDROGEL DRESSING; HYPERBARIC OXYGEN; INFECTION RISK; LASER; LEG ULCER; LOW LEVEL LASER THERAPY; NONHUMAN; PULSED ELECTRIC FIELD; REVIEW; SKIN ULCER; STEM CELL; SUTURE; TISSUE ENGINEERING; TISSUE REGENERATION; ULCER; VACUUM ASSISTED CLOSURE; WOUND CARE; WOUND DRESSING; WOUND HEALING; WOUND INFECTION; ANIMAL; ARTIFICIAL SKIN; BANDAGE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; PROCEDURES;

ANIMALS; BANDAGES; BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; HUMANS; SKIN, ARTIFICIAL; TISSUE ENGINEERING; WOUND HEALING;

EID: 84944175605     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.24610     Document Type: Review

References (360)

1. Boateng JS, Matthews KH, Stevens HN, Eccleston GM,. 2008. Wound healing dressings and drug delivery systems: A review. J Pharm Sci 97 (8): 2892-2923.
2. Enoch S, Leaper DJ,. 2008. Basic science of wound healing. Surgery (Oxford) 26 (2): 31-37.
3. Guo S, Di Pietro LA,. 2010. Factors affecting wound healing. J Dental Res 89 (3): 219-229.
4. Gurtner GC, Callaghan MJ, Longaker MT,. 2007. Progress and potential for regenerative medicine. Annu Rev Med 58: 299-312.
5. Gurtner GC, Werner S, Barrandon Y, Longaker MT,. 2008. Wound repair and regeneration. Nature 453 (7193): 314-321.
6. Martin P,. 1997. Wound healing-Aiming for perfect skin regeneration. Science 276 (5309): 75-81.
7. Nawaz Z, Bentley G,. 2011. Surgical incisions and principles of wound healing. Surgery 29 (2): 59-62.
8. Reinke JM, Sorg H,. 2012. Wound repair and regeneration. Eur Surg Res 49 (1): 35-43.
9. Velnar T, Bailey T, Smrkolj V,. 2009. The wound healing process: An overview of the cellular and molecular mechanisms. J Int Med Res 37 (5): 1528-1542.
10. Thu HE, Zulfakar MH, Ng SF,. 2012. Alginate based bilayer hydrocolloid films as potential slow-release modern wound dressing. Int J Pharm 434 (1-2): 375-383.
11. Percival J,. 2002. Classification of wounds and their management. Surgery 20: 114-117.
12. Moore K, McCallion R, Searle RJ, Stacey MC, Harding KG,. 2006. Prediction and monitoring the therapeutic response of chronic dermal wounds. Int Wound J 3 (2): 89-96.
13. Broderick N,. 2009. Understanding chronic wound healing. Nurse Practitioner 34 (10): 16-22.
14. Trent JT, Kirsner RS,. 2003. Wounds and malignancy. Adv Skin Wound Care 16 (1): 31-34.
15. Cutting KF, White RJ,. 2002. Maceration of the skin and wound bed. 1: Its nature and causes. J Wound Care 11 (7): 275-278.
16. Krasner D, Kennedy KL, Rolstad BS, Roma AW,. 1993. The ABCs of wound care dressings. Ostomy Wound Manage 39 (8): 66, 68-69, 72 passim.
17. Ferreira MC, Tuma P Jr, Carvalho VF, Kamamoto F,. 2006. Complex wounds. Clinics (Sao Paulo) 61 (6): 571-578.
18. Kirketerp-Møller K, Zulkowski K, James G,. 2011. Chronic wound colonization, infection, and biofilms. Biofilm infections. New York: Springer, pp 11-24.
19. Skorkowska-Telichowska K, Czemplik M, Kulma A, Szopa J,. 2013. The local treatment and available dressings designed for chronic wounds. J Am Acad Dermatol 68 (4): e117-e126.
20. Peh K, Khan T, Ch'ng H,. 2000. Mechanical, bioadhesive strength and biological evaluations of chitosan films for wound dressing. J Pharm Pharm Sci 3 (3): 303-311.
21. Geroult S, Phillips RO, Demangel C,. 2014. Adhesion of the ulcerative pathogen mycobacterium ulcerans to DACC-coated dressings. J Wound Care 23 (8): 417-418, 422-414.
22. Bessis D, Kempf M, Marsollier L,. 2015. Mycobacterium ulcerans disease (Buruli ulcer) in Mali: A new potential African endemic country. Acta Derm Venereol 95 (4): 489-490.
23. Bjarnsholt T, Kirketerp-Moller K, Jensen PO, Madsen KG, Phipps R, Krogfelt K, Hoiby N, Givskov M,. 2008. Why chronic wounds will not heal: A novel hypothesis. Wound Repair Regen 16 (1): 2-10.
24. Carter MJ, Tingley-Kelley K, Warriner RA 3rd,. 2010. Silver treatments and silver-impregnated dressings for the healing of leg wounds and ulcers: A systematic review and meta-analysis. J Am Acad Dermatol 63 (4): 668-679.
25. Falanga V,. 2000. Classifications for wound bed preparation and stimulation of chronic wounds. Wound Repair Regen 8 (5): 347-352.
26. Nwomeh BC, Liang HX, Cohen IK, Yager DR,. 1999. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res 81: 189-195.
27. Nwomeh BC, Liang HX, Diegelmann RF, Cohen IK, Yager DR,. 1998. Dynamics of the matrix metalloproteinases MMP-1 and MMP-8 in acute open human dermal wounds. Wound Repair Regen 6: 127-134.
28. Lobmann R, Zacheja S, Houdek P, Moll I, Lobmann R,. 2008. Expression of matrix metalloproteinases, cytokines, and connexins in diabetic and nondiabetic human keratinocytes before and after transplantation into an ex vivo wound-healing model. Diabetes Care 31: 114-120.
29. Bullen EC, Longaker MT, Updike DL, Benton R, Ladin D, Hou Z, Howard EW,. 1995. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 104: 236-240.
30. Weiss SJ,. 1989. Tissue destruction by neutrophils. N Engl J Med 320: 365-376.
31. Rao CN, Ladin DA, Liu YY, Chilukuri K, Hou ZZ, Woodley DT,. 1995. Alpha 1-antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: The inhibitor protects fibronectin from degradation by chronic wound fluid enzymes. J Invest Dermatol 105: 572-578.
32. Grinnell F, Zhu M,. 1996. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin. J Invest Dermatol 106: 335-341.
33. Falanga V,. 1992. Growth factors and chronic wounds: The need to understand the microenvironment. J Dermatol 19: 667-672.
34. Bennett NT, Schultz GS,. 1993. Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg 166: 74-81.
35. Fonder MA, Lazarus GS, Cowan DA, Aronson-Cook B, Kohli AR, Mamelak AJ,. 2008. Treating the chronic wound: A practical approach to the care of nonhealing wounds and wound care dressings. J Am Acad Dermatol 58 (2): 185-206.
36. Jones V, Grey JE, Harding KG,. 2006. Wound dressings. BMJ 332 (7544): 777-780. Accessed May 11, 2015, at: http://www.oxforddictionaries.com/.
37. Langer R,. 1980. Polymeric delivery systems for controlled drug release. Chem Eng Commun 6: 1-48.
38. Slaughter BV, Khurshid SS, Fisher OZ, Khademhosseini A, Peppas NA,. 2009. Hydrogels in regenerative medicine. Adv Mater 21 (32-33): 3307-3329.
39. Martin A, Bustamante P, Chun A,. 1993. Diffusion and dissolution; In 'Physical Pharmacy: Physicochemical Principles in the Pharmaceutical Sciences';, Mundorff G, Ed. 4th ed. Philadelphia, Pennsylvania: Lippincott Williams and Wilkins, pp 324-362.
40. Peppas NA,. 1983. A model of dissolution-controlled solute release from porous drug delivery polymeric systems. J Biomed Mater Res 17 (6): 1079-1087.
41. DuBose JW, Cutshall C, Metters AT,. 2005. Controlled release of tethered molecules via engineered hydrogel degradation: Model development and validation. J Biomed Mater Res A 74 (1): 104-116.
42. Suzuki Y, Tanihara M, Nishimura Y, Suzuki K, Kakimaru Y, Shimizu Y,. 1998. A new drug delivery system with controlled release of antibiotic only in the presence of infection. J Biomed Mater Res 42 (1): 112-116.
43. Mogosanu GD, Grumezescu AM,. 2014. Natural and synthetic polymers for wounds and burns dressing. Int J Pharm 463 (2): 127-136.
44. Rajwade JM, Paknikar KM, Kumbhar JV,. 2015. Applications of bacterial cellulose and its composites in biomedicine. Appl Microbiol Biotechnol 99 (6): 2491-2511.
45. de, Olyveira GM, Manzine Costa LM, Basmaji P, Filho LX,. 2011. Bacterial nanocellulose for medicine regenerative. J Nanotechnol Eng Med 2: 034001.
46. Altman GH, Diaz F, Jakuba C, Calabro T, Horan RL, Chen J, Lu H, Richmond J, Kaplan DL,. 2003. Silk-based biomaterials. Biomaterials 24 (3): 401-416.
47. Grant GT, Morris ER, Rees DA, Smith PJC, Thom D,. 1973. Biological interactions between polysaccharides and divalent cations-Egg-box model. FEBS Lett 32 (1): 195-198.
48. + effects on multi-functional alginate dressings. Carbohydr Polym 87 (2): 1796-1802.
49. Lee KY, Mooney DJ,. 2012. Alginate: Properties and biomedical applications. Prog Polym Sci 37 (1): 106-126.
50. Gilchrist T, Martin AM,. 1983. Wound treatment with Sorbsan-An alginate fibre dressing. Biomaterials 4 (4): 317-320.
51. Sayag J, Meaume S, Bohbot S,. 1996. Healing properties of calcium alginate dressings. J Wound Care 5 (8): 357-362.
52. Frenkel JS,. 2012. The role of hyaluronan in wound healing. Int Wound J 11 (2): 159-163.
53. Humbert P, Mikosinki J, Benchikhi H, Allaert FA,. 2013. Efficacy and safety of a gauze pad containing hyaluronic acid in treatment of leg ulcers of venous or mixed origin: A double-blind, randomised, controlled trial. Int Wound J 10 (2): 159-166.
54. Catanzano O, D'Esposito V, Acierno S, De Caro C, Avagliano C, Ambrosio M, Russo P, Russo R, Miro A, Ungaro F, Calignano A, Formisano P, Quaglia F,. 2015. Alginate-hyaluronan composite hydrogels accelerate wound healing process. Carbohydr Polym 131: 407-414.
55. Ermolov AS, Smirnov SV, Khvatov VB, Istranov LP, Koniushko OI, Kolokolchikova EG, Sychevsky MV, Bocharova VS,. 2008. The use of bioactive wound dressing, stimulating epithelial regeneration of IIIa-degree burn wounds. Bull Exp Biol Med 146 (1): 153-157.
56. Sambasivan R, Yao R, Kissenpfennig A, Van Wittenberghe L, Paldi A, Gayraud-Morel B, Guenou H, Malissen B, Tajbakhsh S, Galy A,. 2011. Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. Development 138 (17): 3647-3656.
57. Urciuolo A, Quarta M, Morbidoni V, Gattazzo F, Molon S, Grumati P, Montemurro F, Tedesco FS, Blaauw B, Cossu G, Vozzi G, Rando TA, Bonaldo P,. 2013. Collagen VI regulates satellite cell self-renewal and muscle regeneration. Nat Commun 4: 1964.
58. Jayakumar R, Prabaharan M, Sudheesh Kumar PT, Nair SV, Tamura H,. 2011. Biomaterials based on chitin and chitosan in wound dressing applications. Biotechnol Adv 29 (3): 322-337.
59. Ueno H, Yamada H, Tanaka I, Kaba N, Matsuura M, Okumura M, Kadosawa T, Fujinaga T,. 1999. Accelerating effects of chitosan for healing at early phase of experimental open wound in dogs. Biomaterials 20 (15): 1407-1414.
60. Unnithan AR, Barakat NA, Pichiah PB, Gnanasekaran G, Nirmala R, Cha YS, Jung CH, El-Newehy M, Kim HY,. 2012. Wound-dressing materials with antibacterial activity from electrospun polyurethane-dextran nanofiber mats containing ciprofloxacin HCl. Carbohydr Polym 90 (4): 1786-1793.
61. Sinha M, Banik RM, Haldar C, Maiti P,. 2013. Development of ciprofloxacin hydrochloride loaded poly(ethylene glycol)/chitosan scaffold as wound dressing. J Porous Mater 20: 799-807.
62. Calo E, Khutoryanskiy V,. 2015. Biomedical applications of hydrogels: A review of patents and commercial products. Eur Polym J 65 (2015): 252-267.
63. Hoare TR, Kohane DS,. 2008. Hydrogels in drug delivery: Progress and challenges. Polymer 49: 1993e, 2007.
64. Jones A, Vaughan D,. 2005. Hydrogel dressings in the management of a variety of wound types: A review. J Orthopaed Med 9: S1-S11.
65. Watson NFS, Hodgkin W,. 2005. Wound dressings. Surgery 23 (2): 52-55.
66. Ahmed EM,. 2015. Hydrogel: Preparation, characterization and applications: A review. J Adv Res 6 (2): 105-121.
67. Rosiak JM, Olejniczak J,. 1993. Medical application of radiation formed hydrogels. Radiat Phys Chem 42: 903.
68. Rosiak JM,. 1991. Hydrogel dressings. In Radiation effects on polymers. Washington, DC: ACS Book Ser, pp 271.
69. Fan LH, Zhou XY, Wu PH, Xie WG, Zheng H, Tan W, Liu SH, Li QY,. 2014. Preparation of carboxymethyl cellulose sulfates and its application as anticoagulant and wound dressing. Int J Biol Macromol 66: 245-253.
70. Nayak S, Kundu SC,. 2014. Sericin-carboxymethyl cellulose porous matrices as cellular wound dressing material. J Biomed Mater Res A 102 (6): 1928-1940.
71. Ng SF, Jumaat N,. 2014. Carboxymethyl cellulose wafers containing antimicrobials: A modern drug delivery system for wound infections. Eur J Pharm Sci 51: 173-179.
72. Lin WC, Lien CC, Yeh HJ, Yu CM, Hsu SH,. 2013. Bacterial cellulose and bacterial cellulose-chitosan membranes for wound dressing applications. Carbohydr Polym 94 (1): 603-611.
73. Wu J, Zheng Y, Song W, Luan J, Wen X, Wu Z, Chen X, Wang Q, Guo S,. 2014. In situ synthesis of silver-nanoparticles/bacterial cellulose composites for slow-released antimicrobial wound dressing. Carbohydr Polym 102: 762-771.
74. Wu J, Zheng Y, Wen X, Lin Q, Chen X, Wu Z,. 2014. Silver nanoparticle/bacterial cellulose gel membranes for antibacterial wound dressing: Investigation in vitro and in vivo. Biomed Mater 9 (3): 035005.
75. De Moraes MA, Beppu MM,. 2013. Biocomposite membranes of sodium algi-nate and silk fibroin fibers for biomedical applications. J Appl Polym Sci 130: 3451-3457.
76. Gobin AS, Froude VE, Mathur AB,. 2005. Structural and mechanical characteristics of silk fibroin and chitosan blend scaffolds for tissue regeneration. J Biomed Mater Res A 74 (3): 465-473.
77. Liu TL, Miao JC, Sheng WH, Xie YF, Huang Q, Shan YB, Yang JC,. 2010. Cyto-compatibility of regenerated silk fibroin film: A medical biomaterial applicableto wound healing. J Zhejiang Univ Sci 11: 10-16.
78. Mishra RK, Majeed ABA, Banthia AK,. 2011. Development and characterizationof pectin/gelatin hydrogel membranes for wound dressing. Int J Plast Technol 15: 82-95.
79. Munarin F, Tanzi MC, Petrini P,. 2012. Advances in biomedical applications of pectin gels. Int J Biol Macromol 51 (4): 681-689.
80. Boateng JS, Pawar HV, Tetteh J,. 2013. Polyox and carrageenan based composite film dressing containing anti-microbial and anti-inflammatory drugs for effective wound healing. Int J Pharm 441 (1-2): 181-191.
81. Pawar HV, Boateng JS, Ayensu I, Tetteh J,. 2014. Multifunctional medicated lyophilised wafer dressing for effective chronic wound healing. J Pharm Sci 103 (6): 1720-1733.
82. Pawar HV, Tetteh J, Boateng JS,. 2013. Preparation, optimisation and characterisation of novel wound healing film dressings loaded with streptomycin and diclofenac. Coll Surf B Biointerfaces 102: 102-110.
83. Zivanovic S, Li J, Davidson PM, Kit K,. 2007. Physical, mechanical, and antibacterial properties of chitosan/PEO blend films. Biomacromolecules 8 (5): 1505-1510.
84. Kamoun EA, Kenawy ERS, Tamer TM, El-Meligy MA, Eldin MSM,. 2015. Poly (vinyl alcohol)-alginate physically crosslinked hydrogel membranes for wound dressing applications: Characterization and bio-evaluation. Arabian J Chem 8 (1): 38-47.
85. Hwang MR, Kim JO, Lee JH, Kim YI, Kim JH, Chang SW, Jin SG, Kim JA, Lyoo WS, Han SS, Ku SK, Yong CS, Choi HG,. 2010. Gentamicin-loaded wound dressing with polyvinyl alcohol/dextran hydrogel: Gel characterization and in vivo healing evaluation. AAPS PharmSciTech 11 (3): 1092-1103.
86. Kamoun EA, Kenawy ERS, Tamer TM, El-Meligy MA, Eldin MSM,. 2015. Poly (vinyl alcohol)-alginate physically crosslinked hydrogel membranes for wound dressing applications: Characterization and bio-evaluation. Arabian J Chem 8 (1): 38-47.
87. Sakai S, Tsumura M, Inoue M, Koga Y, Fukano K, Taya M,. 2013. Polyvinyl alcohol-based hydrogel dressing gellable on-wound via a co-enzymatic reaction triggered by glucose in the wound exudate. J Mater Chem B 1 (38): 5067-5075.
88. Kontogiannopoulos KN, Assimopoulou AN, Tsivintzelis I, Panayiotou C, Papageorgiou VP,. 2011. Electrospun fiber mats containing shikonin and derivatives with potential biomedical applications. Int J Pharm 409 (1-2): 216-228.
89. Lee JS, Kim JK, Chang YH,. 2007. Preparation of collagen/poly(l-lactic acid) composite material for wound dressing. Macromol Res 15 (15): 205-210.
90. Luckachan GE, Pillai CKS,. 2011. Biodegradable polymers-A review on recent trends and emerging perspectives. J Polym Environ 19: 637-676.
91. Shingel KI, Di Stabile L, Marty JP, Faure MP,. 2006. Inflammatory inert poly(ethylene glycol)-protein wound dressing improves healing responses in partial- and full-thickness wounds. Int Wound J 3 (4): 332-342.
92. Bader RA, Herzog KT, Kao WJ,. 2009. A study of diffusion in poly(ethyleneglycol)-gelatin based semi-interpenetrating networks for use in wound healing. Polym Bull 62: 381-389.
93. Gultekin G, Atalay-Oral C, Erkal S, Sahin F, Karastova D, Tantekin-Ersolmaz SB, Guner FS,. 2009. Fatty acid-based polyurethane films for wound dressing applications. J Mater Sci Mater Med 20 (1): 421-431.
94. Yari A, Yeganeh H, Bakhshi H,. 2012. Synthesis and evaluation of novel absorptive and antibacterial polyurethane membranes as wound dressing. J Mater Sci Mater Med 23 (9): 2187-2202.
95. Brett D,. 2008. A review of collagen and collagen-based wound dressings. Wounds 20 (12): 347-356.
96. Fleck CA, Simman R,. 2010. Modern collagen wound dressings: Function and purpose. J Am Col Certif Wound Spec 2 (3): 50-54.
97. Saarai A, Kasparkova V, Sedlacek T, Saha P,. 2013. On the development and characterisation of crosslinked sodium alginate/gelatine hydrogels. J Mech Behav Biomed Mater 18: 152-166.
98. Boateng J, Burgos-Amador R, Okeke O, Pawar H,. 2015. Composite alginate and gelatin based bio-polymeric wafers containing silver sulfadiazine for wound healing. Int J Biol Macromol 79: 63-71.
99. Anisha BS, Sankar D, Mohandas A, Chennazhi KP, Nair SV, Jayakumar R,. 2013. Chitosan-hyaluronan/nano chondroitin sulfate ternary composite sponges for medical use. Carbohydr Polym 92 (2): 1470-1476.
100. Mohandas A, Anisha BS, Chennazhi KP, Jayakumar R,. 2015. Chitosan-hyaluronic acid/VEGF loaded fibrin nanoparticles composite sponges for enhancing angiogenesis in wounds. Coll Surf B Biointerfaces 127: 105-113.
101. Dai M, Zheng X, Xu X, Kong X, Li X, Guo G, Luo F, Zhao X, Wei YQ, Qian Z,. 2009. Chitosan-alginate sponge: Preparation and application in curcumin delivery for dermal wound healing in rat. J Biomed Biotechnol 2009: 595126.
102. Naseri N, Algan C, Jacobs V, John M, Oksman K, Mathew AP,. 2014. Electrospun chitosan-based nanocomposite mats reinforced with chitin nanocrystals for wound dressing. Carbohydr Polym 109: 7-15.
103. Huang X, Sun Y, Nie J, Lu W, Yang L, Zhang Z, Yin H, Wang Z, Hu Q,. 2015. Using absorbable chitosan hemostatic sponges as a promising surgical dressing. Int J Biol Macromol 75: 322-329.
104. Zhang D, Zhou W, Wei B, Wang X, Tang R, Nie J, Wang J,. 2015. Carboxyl-modified poly(vinyl alcohol)-crosslinked chitosan hydrogel films for potential wound dressing. Carbohydr Polym 125: 189-199.
105. Dumville JC, O'Meara S, Deshpande S, Speak K,. 2013. Alginate dressings for healing diabetic foot ulcers. Cochrane Database Syst Rev 6: CD009110.
106. Hrynyk M, Martins-Green M, Barron AE, Neufeld RJ,. 2012. Alginate-PEG sponge architecture and role in the design of insulin release dressings. Biomacromolecules 13 (5): 1478-1485.
107. Josef E, Zilberman M, Bianco-Peled H,. 2010. Composite alginate hydrogels: An innovative approach for the controlled release of hydrophobic drugs. Acta Biomater 6 (12): 4642-4649.
108. Miralles G, Baudoin R, Dumas D, Baptiste D, Hubert P, Stoltz JF, Dellacherie E, Mainard D, Netter P, Payan E,. 2001. Sodium alginate sponges with or without sodium hyaluronate: In vitro engineering of cartilage. J Biomed Mater Res 57 (2): 268-278.
109. Kaiser D, Hafner J, Mayer D, French LE, Lauchli S,. 2013. Alginate dressing and polyurethane film versus paraffin gauze in the treatment of split-thickness skin graft donor sites: A randomized controlled pilot study. Adv Skin Wound Care 26 (2): 67-73.
110. Powers JG, Morton LM, Phillips TJ,. 2013. Dressings for chronic wounds. Dermatol Ther 26 (3): 197-206.
111. White RJ, Cooper R, Kingsley A,. 2001. Wound colonization and infection: The role of topical antimicrobials. Br J Nurs 10 (9): 563-578.
112. White RJ, Cutting K, Kingsley A,. 2006. Topical antimicrobials in the control of wound bioburden. Ostomy Wound Manage 52 (8): 26-58.
113. Lipsky BA, Hoey C,. 2009. Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis 49 (10): 1541-1549.
114. Bowler PG, Duerden BI, Armstrong DG,. 2001. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 14 (2): 244-269.
115. Phillips D, Davey C,. 1997. Wound cleaning versus wound disinfection: A challenging dilemma. Perspectives 21 (4): 15-16.
116. Brook I,. 1996. Aerobic and anaerobic microbiology of necrotizing fasciitis in children. Pediatr Dermatol 13 (4): 281-284.
117. Halbert AR, Stacey MC, Rohr JB, Jopp-McKay A,. 1992. The effect of bacterial colonization on venous ulcer healing. Australas J Dermatol 33 (2): 75-80.
118. Sehgal SC, Arunkumar BK,. 1992. Microbial flora and its significance in pathology of sickle cell disease leg ulcers. Infection 20 (2): 86-88.
119. Twum-Danso K, Grant C, al-Suleiman SA, Abdel-Khader S, al-Awami MS, al-Breiki H, Taha S, Ashoor AA, Wosornu L,. 1992. Microbiology of postoperative wound infection: A prospective study of 1770 wounds. J Hosp Infect 21 (1): 29-37.
120. Ayton M,. 1985. Wound care: Wounds that won't heal. Nurs Times 81 (46):suppl 16-19.
121. Hickey J, Panicucci R, Duan Y, Dinehart K, Murphy J, Kessler J, Gottardi W,. 1997. Control of the amount of free molecular iodine in iodine germicides. J Pharm Pharmacol 49 (12): 1195-1199.
122. Levine NS, Lindberg RB, Mason AD Jr, Pruitt BA Jr,. 1976. The quantitative swab culture and smear: A quick, simple method for determining the number of viable aerobic bacteria on open wounds. J Trauma 16 (2): 89-94.
123. Church D, Elsayed S, Reid O, Winston B, Lindsay R,. 2006. Burn wound infections. Clin Microbiol Rev 19 (2): 403-434.
124. Revathi G, Puri J, Jain BK,. 1998. Bacteriology of burns. Burns 24 (4): 347-349.
125. Vindenes H, Bjerknes R,. 1995. Microbial colonization of large wounds. Burns 21 (8): 575-579.
126. Oncul O, Yildiz S, Gurer US, Yeniiz E, Qyrdedi T, Top C, Gocer P, Akarsu B, Cevikbas A, Cavuslu S,. 2007. Effect of the function of polymorphonuclear leukocytes and interleukin-1 beta on wound healing in patients with diabetic foot infections. J Infect 54 (3): 250-256.
127. Japoni A, Farshad S, Ziyaeyan M, Ziaian S,. 2009. Detection of Van-positive and negative vancomycin resistant entrococci and their antibacterial susceptibility patterns to the newly introduced antibiotics. Pak J Biol Sci 12 (11): 844-851.
128. Hunt TK,. 1981. Surgical wound infections: An overview. Am J Med 70 (3): 712-718.
129. MacMillan BG,. 1980. Infections following burn injury. Surg Clin North Am 60 (1): 185-196.
130. Eddy JJ, Gideonsen MD, Mack GP,. 2008. Practical considerations of using topical honey for neuropathic diabetic foot ulcers: A review. WMJ 107 (4): 187-190.
131. Rizzello L, Pompa PP,. 2014. Nanosilver-based antibacterial drugs and devices: Mechanisms, methodological drawbacks, and guidelines. Chem Soc Rev 43 (5): 1501-1518.
132. Luu YK, Kim K, Hsiao BS, Chu B, Hadjiargyrou M,. 2003. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. J Control Release 89 (2): 341-353.
133. Dutta NK, Annadurai S, Mazumdar K, Dastidar SG, Kristiansen JE, Molnar J, Martins M, Amaral L,. 2007. Potential management of resistant microbial infections with a novel non-antibiotic: The anti-inflammatory drug diclofenac sodium. Int J Antimicrob Agents 30 (3): 242-249.
134. Dutta NK, Mazumdar K, Baek MW, Kim DJ, Na YR, Park SH, Lee HK, Lee BH, Park JH,. 2008. In vitro efficacy of diclofenac against Listeria monocytogenes. Eur J Clin Microbiol Infect Dis 27 (4): 315-319.
135. Dutta NK, Mazumdar K, Seok SH, Park JH,. 2008. The anti-inflammatory drug Diclofenac retains anti-listerial activity in vivo. Lett Appl Microbiol 47 (2): 106-111.
136. Burt S,. 2004. Essential oils: Their antibacterial properties and potential applications in foods-A review. Int J Food Microbiol 94: 223-253.
137. Llorens E, Calderon S, Del Valle LJ, Puiggali J,. 2015. Polybiguanide (PHMB) loaded in PLA scaffolds displaying high hydrophobic, biocompatibility and antibacterial properties. Mater Sci Eng C Mater Biol Appl 50: 74-84.
138. Aoyagi S, Onishi H, Machida Y,. 2007. Novel chitosan wound dressing loaded with minocycline for the treatment of severe burn wounds. Int J Pharm 330 (1-2): 138-145.
139. Stinner DJ, Noel SP, Haggard WO, Watson JT, Wenke JC,. 2010. Local antibiotic delivery using tailorable chitosan sponges: The future of infection control? J Orthop Trauma 24 (9): 592-597.
140. Labovitiadi O, Lamb AJ, Matthews KH,. 2012. In vitro efficacy of antimicrobial wafers against methicillin-resistant Staphylococcus aureus. Ther Deliv 3 (4): 443-455.
141. Labovitiadi O, Lamb AJ, Matthews KH,. 2012. Lyophilised wafers as vehicles for the topical release of chlorhexidine digluconate-Release kinetics and efficacy against Pseudomonas aeruginosa. Int J Pharm 439 (1-2): 157-164.
142. Labovitiadi O, O'Driscoll NH, Lamb AJ, Matthews KH,. 2013. Rheological properties of gamma-irradiated antimicrobial wafers and in vitro efficacy against Pseudomonas aeruginosa. Int J Pharm 453 (2): 462-472.
143. Klueh U, Wagner V, Kelly S, Johnson A, Bryers JD,. 2000. Efficacy of silver-coated fabric to prevent bacterial colonization and subsequent device-based biofilm formation. J Biomed Mater Res 53 (6): 621-631.
144. Davies RL, Etris SF,. 1997. The development and functions of silver in water purification and disease control. Catal Today 36 (1): 107-114.
145. Yamanaka M, Hara K, Kudo J,. 2005. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl Environ Microbiol 71 (11): 7589-7593.
146. Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PK, Chiu JF, Che CM,. 2007. Silver nanoparticles: Partial oxidation and antibacterial activities. J Biol Inorg Chem 12 (4): 527-534.
147. Rai M, Yadav A, Gade A,. 2009. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27 (1): 76-83.
148. Ong SY, Wu J, Moochhala SM, Tan MH, Lu J,. 2008. Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties. Biomaterials 29 (32): 4323-4332.
149. Madhumathi K, Sudheesh Kumar PT, Abhilash S, Sreeja V, Tamura H, Manzoor K, Nair SV, Jayakumar R,. 2010. Development of novel chitin/nanosilver composite scaffolds for wound dressing applications. J Mater Sci Mater Med 21 (2): 807-813.
150. Pant B, Pant HR, Pandeya DR, Panthi G, Nam KT, Hong ST, Kim CS, Kim HY,. 2012. Characterization and antibacterial properties of Ag NPs loaded nylon-6 nanocomposite prepared by one-step electrospinning process. Coll Surf A 395: 94-99.
151. Ciloglu NS, Mert AI, Dogan Z, Demir A, Cevan S, Aksaray S, Tercan M,. 2014. Efficacy of silver-loaded nanofiber dressings in Candida albicans-contaminated full-skin thickness rat burn wounds. J Burn Care Res 35 (5): e317-e320.
152. Lin YH, Hsu WS, Chung WY, Ko TH, Lin JH,. 2014. Evaluation of various silver-containing dressing on infected excision wound healing study. J Mater Sci Mater Med 25 (5): 1375-1386.
153. Archana D, Singh BK, Dutta J, Dutta PK,. 2015. Chitosan-PVP-nano silver oxide wound dressing: In vitro and in vivo evaluation. Int J Biol Macromol 73: 49-57.
154. Gaisford S, Beezer AE, Bishop AH, Walker M, Parsons D,. 2009. An in vitro method for the quantitative determination of the antimicrobial efficacy of silver-containing wound dressings. Int J Pharm 366 (1-2): 111-116.
155. Said J, Dodoo CC, Walker M, Parsons D, Stapleton P, Beezer AE, Gaisford S,. 2014. An in vitro test of the efficacy of silver-containing wound dressings against Staphylococcus aureus and Pseudomonas aeruginosa in simulated wound fluid. Int J Pharm 462 (1-2): 123-128.
156. Fries CA, Ayalew Y, Penn-Barwell JG, Porter K, Jeffery SL, Midwinter MJ,. 2014. Prospective randomised controlled trial of nanocrystalline silver dressing versus plain gauze as the initial post-debridement management of military wounds on wound microbiology and healing. Injury 45 (7): 1111-1116.
157. Gee Kee EL, Kimble RM, Cuttle L, Khan A, Stockton KA,. 2015. Randomized controlled trial of three burns dressings for partial thickness burns in children. Burns 41: 946-955.
158. Lindsay S,. 2011. Silver White paper-Everything you ever wanted to know about the use of silver in wound therapy. Accessed February 17, 2015, at: http://www.systagenix.co.uk/cms/uploads/1458-Silver-WhitePaperA4-LP3-060.pdf.
159. Altman H, Steinberg D, Porat Y, Mor A, Fridman D, Friedman M, Bachrach G,. 2006. In vitro assessment of antimicrobial peptides as potential agents against several oral bacteria. J Antimicrob Chemother 58 (1): 198-201.
160. Reddy KV, Yedery RD, Aranha C,. 2004. Antimicrobial peptides: Premises and promises. Int J Antimicrob Agents 24 (6): 536-547.
161. Alves D, Olivia Pereira M,. 2014. Mini-review: Antimicrobial peptides and enzymes as promising candidates to functionalize biomaterial surfaces. Biofouling 30 (4): 483-499.
162. Ng VW, Chan JM, Sardon H, Ono RJ, Garcia JM, Yang YY, Hedrick JL,. 2014. Antimicrobial hydrogels: A new weapon in the arsenal against multidrug-resistant infections. Adv Drug Deliv Rev 78: 46-62.
163. O'Driscoll NH, Labovitiadi O, Cushnie TP, Matthews KH, Mercer DK, Lamb AJ,. 2013. Production and evaluation of an antimicrobial peptide-containing wafer formulation for topical application. Curr Microbiol 66 (3): 271-278.
164. Gomes AP, Mano JF, Queiroz JA, Gouveia IC,. 2015. Incorporation of antimicrobial peptides on functionalized cotton gauzes for medical applications. Carbohydr Polym 127: 451-461.
165. Miao J, Pangule RC, Paskaleva EE, Hwang EE, Kane RS, Linhardt RJ, Dordick JS,. 2011. Lysostaphin-functionalized cellulose fibers with antistaphylococcal activity for wound healing applications. Biomaterials 32 (36): 9557-9567.
166. Fischetti VA,. 2008. Bacteriophage lysins as effective antibacterials. Curr Opin Microbiol 11 (5): 393-400.
167. Hadaway L,. 2010. Polyhexamethylene biguanide dressing-Another promising tool to reduce catheter-related bloodstream infection. J Assoc Vascul Access 15 (4): 203-205.
168. Piatkowski A, Drummer N, Andriessen A, Ulrich D, Pallua N,. 2011. Randomized controlled single center study comparing a polyhexanide containing bio-cellulose dressing with silver sulfadiazine cream in partial-thickness dermal burns. Burns 37 (5): 800-804.
169. Dilamian M, Montazer M, Masoumi J,. 2013. Antimicrobial electrospun membranes of chitosan/poly(ethylene oxide) incorporating poly(hexamethylene biguanide) hydrochloride. Carbohydr Polym 94 (1): 364-371.
170. White RJ,. 2009. Wound infection-associated pain. J Wound Care 18 (6): 245-249.
171. Glaser R, Kiecolt-Glaser JK, Marucha PT, MacCallum RC, Laskowski BF, Malarkey WB,. 1999. Stress-related changes in pro inflammatory cytokine production in wounds. Arch Gen Psychiatry 56: 450-456.
172. World Union of Wound Healing Societies (WUWHS). 2004. Principles of best practice: Minimising pain at wound dressing-related procedures. A consensus document. London, UK.
173. Glynn C,. 2002. The control of pain associated with chronic leg ulcers. In The Oxford European wound healing course handbook. Oxford, UK: Positif Press, pp 99-109.
174. Jorgensen B, Friis GJ, Gottrup F,. 2006. Pain and quality of life for patients with venous leg ulcers: Proof of concept of the efficacy of Biatain-Ibu, a new pain reducing wound dressing. Wound Repair Regen 14 (3): 233-239.
175. Arapoglou V, Katsenis K, Syrigos KN, Dimakakos EP, Zakopoulou N, Gjodsbol K, Glynn C, Schafer E, Petersen B, Tsoutos D,. 2011. Analgesic efficacy of an ibuprofen-releasing foam dressing compared with local best practice for painful exuding wounds. J Wound Care 20 (7): 319-320, 322-325.
176. Canton I, McKean R, Charnley M, Blackwood KA, Fiorica C, Ryan AJ, MacNeil S,. 2010. Development of an ibuprofen-releasing biodegradable PLA/PGA electrospun scaffold for tissue regeneration. Biotechnol Bioeng 105 (2): 396-408.
177. Fogh K, Andersen MB, Bischoff-Mikkelsen M, Bause R, Zutt M, Schilling S, Schmutz JL, Borbujo J, Jimenez JA, Cartier H, Jorgensen B,. 2012. Clinically relevant pain relief with an ibuprofen-releasing foam dressing: Results from a randomized, controlled, double-blind clinical trial in exuding, painful venous leg ulcers. Wound Repair Regen 20 (6): 815-821.
178. Romanelli M, Dini V, Polignano R, Bonadeo P, Maggio G,. 2009. Ibuprofen slow-release foam dressing reduces wound pain in painful exuding wounds: Preliminary findings from an international real-life study. J Dermatol Treat 20 (1): 19-26.
179. Bigliardi PL, Neumann C, Teo YL, Pant A, Bigliardi-Qi M,. 2015. Activation of the delta-opioid receptor promotes cutaneous wound healing by affecting keratinocyte intercellular adhesion and migration. Br J Pharmacol 172 (2): 501-514.
180. Stein C, Kuchler S,. 2013. Targeting inflammation and wound healing by opioids. Trends Pharmacol Sci 34 (6): 303-312.
181. Heilmann S, Kuchler S, Wischke C, Lendlein A, Stein C, Schafer-Korting M,. 2013. A thermosensitive morphine-containing hydrogel for the treatment of large-scale skin wounds. Int J Pharm 444 (1-2): 96-102.
182. Chen FM, Zhang M, Wu ZF,. 2010. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 31 (24): 6279-6308.
183. Taipale J, Keski-Oja J,. 1997. Growth factors in the extracellular matrix. FASEB J 11 (1): 51-59.
184. Schultz GS, Wysocki A,. 2009. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 17 (2): 153-162.
185. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M,. 2008. Growth factors and cytokines in wound healing. Wound Repair Regen 16 (5): 585-601.
186. Barrientos S, Brem H, Stojadinovic O, Tomic-Canic M,. 2014. Clinical application of growth factors and cytokines in wound healing. Wound Repair Regen 22 (5): 569-578.
187. Smith & Nephew Website. REGRANEX (becaplermin) gel 0.01%. Accessed January 31, 2015, at: http://www.smith-nephew.com/key-products/advanced-wound-management/regranex-becaplermin-gel./.
188. Food and Drug Administration. 2008. Regranex. Accessed January 31, 2015, at: http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM142821.pdf.
189. Fang RC, Galiano RD,. 2008. A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers. Biologics 2 (1): 1-12.
190. Steed DL,. 1995. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic ulcer study group. J Vasc Surg 21 (1): 71-78; discussion 79-81.
191. Wieman TJ, Smiell JM, Su Y,. 1998. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care 21 (5): 822-827.
192. Margolis DJ, Bartus C, Hoffstad O, Malay S, Berlin JA,. 2005. Effectiveness of recombinant human platelet-derived growth factor for the treatment of diabetic neuropathic foot ulcers. Wound Repair Regen 13 (6): 531-536.
193. Tanaka A, Nagate T, Matsuda H,. 2005. Acceleration of wound healing by gelatin film dressings with epidermal growth factor. J Vet Med Sci 67 (9): 909-913.
194. Ulubayram K, Nur Cakar A, Korkusuz P, Ertan C, Hasirci N,. 2001. EGF containing gelatin-based wound dressings. Biomaterials 22 (11): 1345-1356.
195. Ribeiro MP, Morgado PI, Miguel SP, Coutinho P, Correia IJ,. 2013. Dextran-based hydrogel containing chitosan microparticles loaded with growth factors to be used in wound healing. Mater Sci Eng C Mater Biol Appl 33 (5): 2958-2966.
196. Lai HJ, Kuan CH, Wu HC, Tsai JC, Chen TM, Hsieh DJ, Wang TW,. 2014. Tailored design of electrospun composite nanofibers with staged release of multiple angiogenic growth factors for chronic wound healing. Acta Biomater 10 (10): 4156-4166.
197. Wang W, Lin S, Xiao Y, Huang Y, Tan Y, Cai L, Li X,. 2008. Acceleration of diabetic wound healing with chitosan-crosslinked collagen sponge containing recombinant human acidic fibroblast growth factor in healing-impaired STZ diabetic rats. Life Sci 82 (3-4): 190-204.
198. Zamani M, Prabhakaran MP, Ramakrishna S,. 2013. Advances in drug delivery via electrospun and electrosprayed nanomaterials. Int J Nanomedicine 8: 2997-3017.
199. Yang Y, Xia T, Zhi W, Wei L, Weng J, Zhang C, Li X,. 2011. Promotion of skin regeneration in diabetic rats by electrospun core-sheath fibers loaded with basic fibroblast growth factor. Biomaterials 32 (18): 4243-4254.
200. Choi JS, Leong KW, Yoo HS,. 2008. In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials 29 (5): 587-596.
201. Kulkarni A, Diehl-Jones W, Ghanbar S, Liu S,. 2014. Layer-by-layer assembly of epidermal growth factors on polyurethane films for wound closure. J Biomater Appl 29 (2): 278-290.
202. Jazwa A, Kucharzewska P, Leja J, Zagorska A, Sierpniowska A, Stepniewski J, Kozakowska M, Taha H, Ochiya T, Derlacz R, Vahakangas E, Yla-Herttuala S, Jozkowicz A, Dulak J,. 2010. Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice. Genet Vaccines Ther 8: 6.
203. Mazzucco L, Borzini P, Gope R,. 2010. Platelet-derived factors involved in tissue repair-from signal to function. Transfus Med Rev 24 (3): 218-234.
204. Barsotti MC, Losi P, Briganti E, Sanguinetti E, Magera A, Al Kayal T, Feriani R, Di Stefano R, Soldani G,. 2013. Effect of platelet lysate on human cells involved in different phases of wound healing. PLoS One 8 (12): e84753.
205. Rossi S, Faccendini A, Bonferoni MC, Ferrari F, Sandri G, Del Fante C, Perotti C, Caramella CM,. 2013. "Sponge-like" dressings based on biopolymers for the delivery of platelet lysate to skin chronic wounds. Int J Pharm 440 (2): 207-215.
206. Sandri G, Bonferoni MC, Rossi S, Ferrari F, Mori M, Del Fante C, Perotti C, Scudeller L, Caramella C,. 2011. Platelet lysate formulations based on mucoadhesive polymers for the treatment of corneal lesions. J Pharm Pharmacol 63 (2): 189-198.
207. Sandri G, Bonferoni MC, Rossi S, Ferrari F, Mori M, Del Fante C, Perotti C, Caramella C,. 2012. Thermosensitive eyedrops containing platelet lysate for the treatment of corneal ulcers. Int J Pharm 426 (1-2): 1-6.
208. Mori M, Rossi S, Bonferoni MC, Ferrari F, Sandri G, Riva F, Del Fante C, Perotti C, Caramella C,. 2014. Calcium alginate particles for the combined delivery of platelet lysate and vancomycin hydrochloride in chronic skin ulcers. Int J Pharm 461 (1-2): 505-513.
209. Branski LK, Pereira CT, Herndon DN, Jeschke MG,. 2007. Gene therapy in wound healing: Present status and future directions. Gene Ther 14 (1): 1-10.
210. Hengge UR, Chan EF, Foster RA, Walker PS, Vogel JC,. 1995. Cytokine gene expression in epidermis with biological effects following injection of naked DNA. Nat Genet 10 (2): 161-166.
211. Cam C, Segura T,. 2013. Matrix-based gene delivery for tissue repair. Curr Opin Biotechnol 24 (5): 855-863.
212. Breen AM, Dockery P, O'Brien T, Pandit AS,. 2008. The use of therapeutic gene eNOS delivered via a fibrin scaffold enhances wound healing in a compromised wound model. Biomaterials 29 (21): 3143-3151.
213. Chandler LA, Gu DL, Ma C, Gonzalez AM, Doukas J, Nguyen T, Pierce GF, Phillips ML,. 2000. Matrix-enabled gene transfer for cutaneous wound repair. Wound Repair Regen 8 (6): 473-479.
214. Gu DL, Nguyen T, Gonzalez AM, Printz MA, Pierce GF, Sosnowski BA, Phillips ML, Chandler LA,. 2004. Adenovirus encoding human platelet-derived growth factor-B delivered in collagen exhibits safety, biodistribution, and immunogenicity profiles favorable for clinical use. Mol Ther 9 (5): 699-711.
215. Felgner PL, Rhodes G,. 1991. Gene therapeutics. Nature 349 (6307): 351-352.
216. Lee PY, Li Z, Huang L,. 2003. Thermosensitive hydrogel as a Tgf-beta1 gene delivery vehicle enhances diabetic wound healing. Pharm Res 20 (12): 1995-2000.
217. Kong HJ, Kim ES, Huang YC, Mooney DJ,. 2008. Design of biodegradable hydrogel for the local and sustained delivery of angiogenic plasmid DNA. Pharm Res 25 (5): 1230-1238.
218. Saraf A, Baggett LS, Raphael RM, Kasper FK, Mikos AG,. 2010. Regulated non-viral gene delivery from coaxial electrospun fiber mesh scaffolds. J Control Release 143 (1): 95-103.
219. Layliev J, Wilson S, Warren SM, Saadeh PB,. 2012. Improving wound healing with topical gene therapy. Adv Wound Care (New Rochelle) 1 (5): 218-223.
220. Kozielski KL, Tzeng SY, Green JJ,. 2013. Bioengineered nanoparticles for siRNA delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 5 (5): 449-468.
221. Nelson CE, Kim AJ, Adolph EJ, Gupta MK, Yu F, Hocking KM, Davidson JM, Guelcher SA, Duvall CL,. 2014. Tunable delivery of siRNA from a biodegradable scaffold to promote angiogenesis in vivo. Adv Mater 26 (4): 607-614, 506.
222. Kim HS, Yoo HS,. 2013. Matrix metalloproteinase-inspired suicidal treatments of diabetic ulcers with siRNA-decorated nanofibrous meshes. Gene Ther 20 (4): 378-385.
223. Castleberry S, Wang M, Hammond PT,. 2013. Nanolayered siRNA dressing for sustained localized knockdown. ACS Nano 7 (6): 5251-5261.
224. Cha J, Falanga V,. 2007. Stem cells in cutaneous wound healing. Clin Dermatol 25 (1): 73-78.
225. Chen JS, Wong VW, Gurtner GC,. 2012. Therapeutic potential of bone marrow-derived mesenchymal stem cells for cutaneous wound healing. Front Immunol 3: 192.
226. Cherubino M, Rubin JP, Miljkovic N, Kelmendi-Doko A, Marra KG,. 2011. Adipose-derived stem cells for wound healing applications. Ann Plast Surg 66 (2): 210-215.
227. Branski LK, Gauglitz GG, Herndon DN, Jeschke MG,. 2009. A review of gene and stem cell therapy in cutaneous wound healing. Burns 35 (2): 171-180.
228. Yolanda MM, Maria AV, Amaia FG, Marcos PB, Silvia PL, Escudero D, Jesús OH,. 2014. Adult stem cell therapy in chronic wound healing. J Stem Cell Res Ther 4 (1): 1-6.
229. Yoshikawa T, Mitsuno H, Nonaka I, Sen Y, Kawanishi K, Inada Y, Takakura Y, Okuchi K, Nonomura A,. 2008. Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg 121 (3): 860-877.
230. Hunt NC, Grover LM,. 2010. Cell encapsulation using biopolymer gels for regenerative medicine. Biotechnol Lett 32 (6): 733-742.
231. Seol D, Magnetta MJ, Ramakrishnan PS, Kurriger GL, Choe H, Jang K, Martin JA, Lim TH,. 2013. Biocompatibility and preclinical feasibility tests of a temperature-sensitive hydrogel for the purpose of surgical wound pain control and cartilage repair. J Biomed Mater Res B Appl Biomater 101 (8): 1508-1515.[Epub ahead of print]
232. Dong YX, Hassan WU, Kennedy R, Greiser U, Pandit A, Garcia Y, Wang WX,. 2014. Performance of an in situ formed bioactive hydrogel dressing from a PEG-based hyperbranched multifunctional copolymer. Acta Biomater 10 (5): 2076-2085.
233. Davis SC, Perez R,. 2009. Cosmeceuticals and natural products: wound healing. Clin Dermatol 27 (5): 502-506.
234. Ni Y, Yates KM, Tizard IR,. 2004. Aloes: The genus Aloe. In, Reynolds T, ed. New York: CRC Press LLC.
235. Djeraba A, Quere P,. 2000. In vivo macrophage activation in chickens with Acemannan, a complex carbohydrate extracted from Aloe vera. Int J Immunopharmacol 22 (5): 365-372.
236. Boudreau MD, Beland FA,. 2006. An evaluation of the biological and toxicological properties of Aloe barbadensis (Miller), Aloe vera. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 24 (1): 103-154.
237. Inpanya P, Faikrua A, Ounaroon A, Sittichokechaiwut A, Viyoch J,. 2012. Effects of the blended fibroin/aloe gel film on wound healing in streptozotocin-induced diabetic rats. Biomed Mater 7 (3): 035008.
238. Pereira R, Carvalho A, Vaz DC, Gil MH, Mendes A, Bartolo P,. 2013. Development of novel alginate based hydrogel films for wound healing applications. Int J Biol Macromol 52: 221-230.
239. Silva SS, Caridade SG, Mano JF, Reis RL,. 2013. Effect of crosslinking in chitosan/aloe vera-based membranes for biomedical applications. Carbohydr Polym 98 (1): 581-588.
240. Motealleh B, Zahedi P, Rezaeian I, Moghimi M, Abdolghaffari AH, Zarandi MA,. 2014. Morphology, drug release, antibacterial, cell proliferation, and histology studies of chamomile-loaded wound dressing mats based on electrospun nanofibrous poly(varepsilon-caprolactone)/polystyrene blends. J Biomed Mater Res B Appl Biomater 102 (5): 977-987.
241. Antonio F, Guillem R, Sonia T, Clara M, Piergiorgio G, Valeria C, Gianluca C, Tzanov T,. 2011. Cross-linked collagen sponges loaded with plant polyphenols with inhibitory activity towards chronic wound enzymes. Biotechnol J 6 (10): 1208-1218.
242. Tan SP, McLoughlin P, O'Sullivan L, Prieto ML, Gardiner GE, Lawlor PG, Hughes H,. 2013. Development of a novel antimicrobial seaweed extract-based hydrogel wound dressing. Int J Pharm 456 (1): 10-20.
243. Bhatnagar M, Parwani L, Sharma V, Ganguli J, Bhatnagar A,. 2013. Hemostatic, antibacterial biopolymers from Acacia arabica (Lam.) Willd. and Moringa oleifera (Lam.) as potential wound dressing materials. Indian J Exp Biol 51 (10): 804-810.
244. Muthukumar T, Prabu P, Ghosh K, Sastry TP,. 2014. Fish scale collagen sponge incorporated with Macrotyloma uniflorum plant extract as a possible wound/burn dressing material. Coll Surf B Biointerfaces 113: 207-212.
245. Dorai AA,. 2012. Wound care with traditional, complementary and alternative medicine. Indian J Plast Surg 45 (2): 418-424.
246. Hammer KA, Carson CF, Riley TV,. 1999. Antimicrobial activity of essential oils and other plant extracts. J Appl Microbiol 86 (6): 985-990.
247. Liakos I, Rizzello L, Scurr DJ, Pompa PP, Bayer IS, Athanassiou A,. 2014. All-natural composite wound dressing films of essential oils encapsulated in sodium alginate with antimicrobial properties. Int J Pharm 463 (2): 137-145.
248. Catanzano O, Straccia MC, Miro A, Ungaro F, Romano I, Mazzarella G, Santagata G, Quaglia F, Laurienzo P, Malinconico M,. 2014. Spray-by-spray in situ cross-linking alginate hydrogels delivering a tea tree oil microemulsion. Eur J Pharm Sci 66C: 20-28.
249. Altiok D, Altiok E, Tihminlioglu F,. 2010. Physical, antibacterial and antioxidant properties of chitosan films incorporated with thyme oil for potential wound healing applications. J Mater Sci Mater Med 21 (7): 2227-2236.
250. Kavoosi G, Dadfar SMM, Purfard AM,. 2013. Mechanical, physical, antioxidant, and antimicrobial properties of gelatin films incorporated with thymol for potential use as nano wound dressing. J Food Scie 78 (2): E244-E250.
251. Dias AM, Braga ME, Seabra IJ, Ferreira P, Gil MH, de Sousa HC,. 2011. Development of natural-based wound dressings impregnated with bioactive compounds and using supercritical carbon dioxide. Int J Pharm 408 (1-2): 9-19.
252. Anghel I, Holban AM, Grumezescu AM, Andronescu E, Ficai A, Anghel AG, Maganu M, Laz RV, Chifiriuc MC,. 2012. Modified wound dressing with phyto-nanostructured coating to prevent staphylococcal and pseudomonal biofilm development. Nanoscale Res Lett 7 (1): 690.
253. Charernsriwilaiwat N, Rojanarata T, Ngawhirunpat T, Sukma M, Opanasopit P,. 2013. Electrospun chitosan-based nanofiber mats loaded with Garcinia mangostana extracts. Int J Pharm 452 (1-2): 333-343.
254. Molan P,. 2001. Honey as a topical antibacterial agent for treatment of infected wounds. Am J Clin Dermatol 2 (1): 13-19.
255. Mandal S, Mandal M,. 2011. Honey: Its medicinial properties and antibacteria activity. Asian Pacif J Trop Biomed 1: 154-160.
256. Bansal V, Medhi B, Pandhi, 2005. Honey-A remedy rediscovered and its therapeutic utility. Kathmandu Univ Med J (KUMJ) 3: 305-309.
257. Eteraf-Oskouei T, Najafi M,. 2013. Traditional and modern uses of natural honey in human diseases: A review. Iranian J Basic Med Sci 16 (6): 731-742.
258. Molan P,. 2009. Debridement of wounds with honey. J Wound Tech 5: 12-18.
259. Molan P,. 2011. The evidence and the rationale for the use of honey as a wound dressing. Wound Pract Res 19 (4): 201-221.
260. Seckam A, Cooper R,. 2013. Understanding how honey impacts on wounds: An update on recent research findings. Wounds Int 4 (1): 20-24.
261. Schneider M, Coyle S, Warnock M, Gow I, Fyfe L,. 2013. Anti-microbial activity and composition of manuka and portobello honey. Phytother Res 27 (8): 1162-1168.
262. Cantarelli M, Pellerano R, Marchevsky E, Camina JM,. 2008. Quality of honey from Argentina: Study of chemical composition and trace elements. J Arg Chem Soc 96: 33-41.
263. White JW, Doner LW,. 1980. Honey composition and properties. In Beekeeping in the United States. Philadelphia, Pennsylvania: Science and Education Administration, Eastern Regional Research Center, pp 82-92.
264. Khalil MI, Sulaiman SA,. 2010. The potential role of honey and its polyphenols in preventing heart diseases: A review. Afric J Trad Complement Alt Med 7 (4): 315-321.
265. Hill KE, Malic S, McKee R, Rennison T, Harding KG, Williams DW, Thomas DW,. 2010. An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptibilities. J Antimicrob Chemother 65 (6): 1195-1206.
266. Molan P,. 2012. The antibacterial activity of honey and its role in treating diseases. Academia.edu 2012a, pp. 1-18.
267. White JW, Subers MH, Schepartz AI,. 1963. The identification of inhibine, the antibacterial factor in honey as hydrogen peroxide and its origin in a honey glucose-oxidase system. Biochim Biophys Acta 73: 57-70.
268. Brudzynski K,. 2006. Effect of hydrogen peroxide on antibacterial activities of Canadian honeys. Can J Microbiol 52 (12): 1228-1237.
269. Molan P,. 1992. The antibacterial activity of honey.1.The nature of the antibacterial activity. Bee World 73 (1): 5-28.
270. Bogdanov S, Martin P, Lullmann C, Borneck R, Flamini C, Morlot M, Vorwohl G,. 1997. Harmonised methods of the European Honey Commission. Apidol 28: 1-59.
271. Molan P,. 2001. Why honey is effective as a medicine. Bee World 82 (1): 22-40.
272. Mohrig W, Messner B,. 1968. Lysozyme as an antibacterial agent in honey and bee venom. Acta Biol Med Ger 21: 85-95.
273. Estevinho L, Pereira AP, Moreira L, Dias LG, Pereira E,. 2008. Antioxidant and antimicrobial effects of phenolic compounds extracts of Northeast Portugal honey. Food Chem Toxicol 46 (12): 3774-3779.
274. Jull AB, Cullum N, Dumville JC, Westby MJ, Deshpande S, Walker N,. 2015. Honey as a topical treatment for wounds. Cochrane Database Syst Rev 3: CD005083.
275. Lay-flurrie K,. 2008. Honey in wound care: Effects, clinical application and patient benefit. Br J Nurs 17 (11): S30, S32-36.
276. Visavadia BG, Honeysett J, Danford M,. 2008. Manuka honey dressing: An effective treatment for chronic wound infections. Br J Oral Maxillofac Surg 46 (8): 696-697.
277. Kamaratos AV, Tzirogiannis KN, Iraklianou SA, Panoutsopoulos GI, Kanellos IE, Melidonis AI,. 2014. Manuka honey-impregnated dressings in the treatment of neuropathic diabetic foot ulcers. Int Wound J 11 (3): 259-263.
278. Mavric E, Wittmann S, Barth G, Henle T,. 2008. Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res 52 (4): 483-489.
279. Cooke J, Dryden M, Patton T, Brennan J, Barrett J,. 2015. The antimicrobial activity of prototype modified honeys that generate reactive oxygen species (ROS) hydrogen peroxide. BMC Res Notes 8: 20.
280. Dryden M, Tawse C, Adams J, Howard A, Saeed K, Cooke J,. 2014. The use of Surgihoney to prevent or eradicate bacterial colonisation in dressing oncology long vascular lines. J Wound Care 23 (6): 338-341.
281. Iyyam, Pillai S, Palsamy P, Subramanian S, Kandaswamy M,. 2010. Wound healing properties of Indian propolis studied on excision wound-induced rats. Pharm Biol 48 (11): 1198-1206.
282. McLennan SV, Bonner J, Milne S, Lo L, Charlton A, Kurup S, Jia J, Yue DK, Twigg SM,. 2008. The anti-inflammatory agent Propolis improves wound healing in a rodent model of experimental diabetes. Wound Repair Regen 16 (5): 706-713.
283. de Almeida EB, Cordeiro Cardoso J, Karla de Lima A, de Oliveira NL, de Pontes-Filho NT, Oliveira Lima S, Leal Souza IC, de Albuquerque-Junior RL,. 2013. The incorporation of Brazilian propolis into collagen-based dressing films improves dermal burn healing. J Ethnopharmacol 147 (2): 419-425.
284. Pillai CK, Sharma CP,. 2010. Review paper: Absorbable polymeric surgical sutures: Chemistry, production, properties, biodegradability, and performance. J Biomater Appl 25 (4): 291-366.
285. Hranjec T, Swenson BR, Sawyer RG,. 2010. Surgical site infection prevention: How we do it. Surg Infect (Larchmt) 11 (3): 289-294.
286. Mingmalairak C,. 2011. Antimicrobial sutures: New strategy in surgical site infections. In Science against microbial pathogens: Communicating current research and technological advances;, Mendez-Vilas A, ed. Badajoz, Spain: Formatex Research Center, pp 313-323.
287. Gomez-Alonso A, Garcia-Criado FJ, Parreno-Manchado FC, Garcia-Sanchez JE, Garcia-Sanchez E, Parreno-Manchado A, Zambrano-Cuadrado Y,. 2007. Study of the efficacy of coated VICRYL plus antibacterial suture (coated polyglactin 910 suture with triclosan) in two animal models of general surgery. J Infect 54 (1): 82-88.
288. Obermeier A, Schneider J, Wehner S, Matl FD, Schieker M, von Eisenhart-Rothe R, Stemberger A, Burgkart R,. 2014. Novel high efficient coatings for anti-microbial surgical sutures using chlorhexidine in fatty acid slow-release carrier systems. PLoS One 9 (7): e101426.
289. Blaker JJ, Nazhat SN, Boccaccini AR,. 2004. Development and characterisation of silver-doped bioactive glass-coated sutures for tissue engineering and wound healing applications. Biomaterials 25 (7-8): 1319-1329.
290. Zhang SW, Liu XL, Wang HL, Peng J, Wong KKY,. 2014. Silver nanoparticle-coated suture effectively reduces inflammation and improves mechanical strength at intestinal anastomosis in mice. J Pediatr Surg 49 (4): 606-613.
291. Bigalke C, Luderer F, Wulf K, Storm T, Lobler M, Arbeiter D, Rau BM, Nizze H, Vollmar B, Schmitz KP, Klar E, Sternberg K,. 2014. VEGF-releasing suture material for enhancement of vascularization: Development, in vitro and in vivo study. Acta Biomaterials 10 (12): 5081-5089.
292. Fuchs TF, Surke C, Stange R, Quandte S, Wildemann B, Raschke MJ, Schmidmaier G,. 2012. Local delivery of growth factors using coated suture material. ScientificWorldJournal 2012: 109216.
293. Dines JS, Weber L, Razzano P, Prajapati R, Timmer M, Bowman S, Bonasser L, Dines DM, Grande DP,. 2007. The effect of growth differentiation factor-5-coated sutures on tendon repair in a rat model. J Shoulder Elbow Surg 16 (5 Suppl): S215-S221.
294. Reckhenrich AK, Kirsch BM, Wahl EA, Schenck TL, Rezaeian F, Harder Y, Foehr P, Machens HG, Egana JT,. 2014. Surgical sutures filled with adipose-derived stem cells promote wound healing. PLoS One 9 (3): e91169.
295. Pasternak B, Missios A, Askendal A, Tengvall P, Aspenberg P,. 2007. Doxycycline-coated sutures improve the suture-holding capacity of the rat Achilles tendon. Acta Orthop 78 (5): 680-686.
296. Guyette JP, Fakharzadeh M, Burford EJ, Tao ZW, Pins GD, Rolle MW, Gaudette GR,. 2013. A novel suture-based method for efficient transplantation of stem cells. J Biomed Mater Res A 101 (3): 809-818.
297. Lee JE, Park S, Park M, Kim MH, Park CG, Lee SH, Choi SY, Kim BH, Park HJ, Park JH, Heo CY, Choy YB,. 2013. Surgical suture assembled with polymeric drug-delivery sheet for sustained, local pain relief. Acta Biomater 9 (9): 8318-8327.
298. He CL, Huang ZM, Han XJ,. 2009. Fabrication of drug-loaded electrospun aligned fibrous threads for suture applications. J Biomed Mater Res A 89 (1): 80-95.
299. Weldon CB, Tsui JH, Shankarappa SA, Nguyen VT, Ma M, Anderson DG, Kohane DS,. 2012. Electrospun drug-eluting sutures for local anesthesia. J Control Release 161 (3): 903-909.
300. Costantino U, Ambrogi V, Nocchetti M, Perioli L,. 2008. Hydrotalcite-like compounds: Versatile layered hosts of molecular anions with biological activity. Micropor Mesopor Mater 107: 149-160.
301. Catanzano O, Acierno S, Russo P, Cervasio M, Del Basso De Caro M, Bolognese A, Sammartino G, Califano L, Marenzi G, Calignano A, Acierno D, Quaglia F,. 2014. Melt-spun bioactive sutures containing nanohybrids for local delivery of anti-inflammatory drugs. Mater Sci Eng C Mater Biol Appl 43: 300-309.
302. Mansbridge JN,. 2013. Tissue-engineered skin substitutes. In Biomaterials science: An introduction to materials in medicine. 3rd ed. Atlanta Georgia: Elsevier Inc, pp 1276-1288.
303. Limova M,. 2010. Active wound coverings: Bioengineered skin and dermal substitutes. Surg Clin North Am 90 (6): 1237-1255.
304. Auger FA, Lacroix D, Germain L,. 2009. Skin substitutes and wound healing. Skin Pharmacol Physiol 22 (2): 94-102.
305. Hartmann-Fritsch F, Biedermann T, Braziulis E, Luginbühl J, Pontiggia L, Böttcher-Haberzeth S, van Kuppevelt TH, Faraj KA, Schiestl C, Meuli M, Reichmann E,. 2012. Collagen hydrogels strengthened by biodegradable meshes are a basis for dermo-epidermal skin grafts intended to reconstitute human skin in a one-step surgical intervention. J Tissue Eng Regen Med 28 (6): 540-556. [Epub ahead of print]
306. Unnithan AR, Barakat NA, Pichiah PB, Gnanasekarane G, Nirmala R, Cha YS, Jung CH, El-Newehy M, Kim HY,. 2012. Wound-dressing materials with antibacterial activity from electrospun polyurethane-dextran nanofiber mats containing ciprofloxacin HCl. Carbohyd Polym 90 (4): 1786-1793.
307. Jin G, Prabhakaran MP, Kai D, Annamalai SK, Arunachalam KD, Ramakrishna S,. 2013. Tissue engineered plant extracts as nanofibrous wound dressing. Biomaterials 34: 724-734.
308. Michael S, Sorg H, Peck CT, Reimers K, Vogt PM,. 2013. The mouse dorsal skin fold chamber as a means for the analysis of tissue engineered skin. Burns 39 (1): 82-88.
309. Morissette Martin P, Maux A, Laterreur V, Mayrand D, L Gagne V, Moulin VJ, Fradette J,. 2015. Enhancing repair of full-thickness excisional wounds in a murine model: Impact of tissue-engineered biological dressings featuring human differentiated adipocytes. Acta Biomater 22: 39-49.
310. Netchiporouk E, Armour A, De Oliveira A,. 2010. Development of epidermal-dermal tissue engineered skin substitutes. J Am Acad Dermatol 62 (3): Ab144-Ab144.
311. Keck M, Haluza D, Lumenta DB, Burjak S, Eisenbock B, Kamolz LP, Frey M,. 2011. Construction of a multi-layer skin substitute: Simultaneous cultivation of keratinocytes and preadipocytes on a dermal template. Burns 37 (4): 626-630.
312. Sharma K, Bullock A, Ralston D, MacNeil S,. 2014. Development of a one-step approach for the reconstruction of full thickness skin defects using minced split thickness skin grafts and biodegradable synthetic scaffolds as a dermal substitute. Burns 40 (5): 957-965.
313. Wahab N, Roman M, Chakravarthy D, Luttrell T,. 2015. The use of a pure native collagen dressing for wound bed preparation prior to use of a living bi-layered skin substitute. J Am Coll Clin Wound Spec doi: 10.1016/j.jccw.2015.03.002. [Epub ahead of print]
314. Huang S, Lu G, Wu Y, Jirigala E, Xu Y, Ma K, Fu X,. 2012. Mesenchymal stem cells delivered in a microsphere-based engineered skin contribute to cutaneous wound healing and sweat gland repair. J Dermatol Sci 66 (1): 29-36.
315. Klar AS, Guven S, Biedermann T, Luginbuhl J, Bottcher-Haberzeth S, Meuli-Simmen C, Meuli M, Martin I, Scherberich A, Reichmann E,. 2014. Tissue-engineered dermo-epidermal skin grafts prevascularized with adipose-derived cells. Biomaterials 35 (19): 5065-5078.
316. Brimson CH, Nigam Y,. 2013. The role of oxygen-associated therapies for the healing of chronic wounds, particularly in patients with diabetes. J Eur Acad Dermatol Venereol 27 (4): 411-418.
317. Chambers AC, Leaper DJ,. 2011. Role of oxygen in wound healing: A review of evidence. J Wound Care 20 (4): 160-164.
318. Rodriguez PG, Felix FN, Woodley DT, Shim EK,. 2008. The role of oxygen in wound healing: A review of the literature. Dermatol Surg 34 (9): 1159-1169.
319. Hunter S, Langemo DK, Anderson J, Hanson D, Thompson P,. 2010. Hyperbaric oxygen therapy for chronic wounds. Adv Skin Wound Care 23 (3): 116-119.
320. Duzgun AP, Satir HZ, Ozozan O, Saylam B, Kulah B, Coskun F,. 2008. Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. J Foot Ankle Surg 47 (6): 515-519.
321. Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE,. 2012. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 4: CD004123.
322. Abidia A, Laden G, Kuhan G, Johnson BF, Wilkinson AR, Renwick PM, Masson EA, McCollum PT,. 2003. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: A double-blind randomised-controlled trial. Eur J Vasc Endovasc Surg 25 (6): 513-518.
323. Blackman E, Moore C, Hyatt J, Railton R, Frye C,. 2010. Topical wound oxygen therapy in the treatment of severe diabetic foot ulcers: A prospective controlled study. Ostomy Wound Manage 56 (6): 24-31.
324. Heng MC, Harker J, Bardakjian VB, Ayvazian H,. 2000. Enhanced healing and cost-effectiveness of low-pressure oxygen therapy in healing necrotic wounds: A feasibility study of technology transfer. Ostomy Wound Manage 46 (3): 52-60, 62.
325. Kellar RS, Audet RG, Roe DF, Rheins LA, Draelos ZD,. 2013. Topically delivered dissolved oxygen reduces inflammation and positively influences structural proteins in healthy intact human skin. J Cosmet Dermatol 12 (2): 86-95.
326. Lairet KF, Baer D, Leas ML, Renz EM, Cancio LC,. 2014. Evaluation of an oxygen-diffusion dressing for accelerated healing of donor-site wounds. J Burn Care Res 35 (3): 214-218.
327. Zellner S, Manabat R, Roe DF,. 2015. A dissolved oxygen dressing: A pilot study in an ischemic skin flap model. J Int Med Res 43 (1): 93-103.
328. Moffatt CJ, Stanton J, Murray S, Doody V, Davis PJ, Franks PJ,. 2014. A randomised trial to compare the performance of Oxyzyme® and Iodozyme® with standard care in the treatment of patients with venous and mixed venous/arterial ulceration. Wound Med 6: 1-10.
329. Vig S, Dowsett C, Berg L, Caravaggi C, Rome P, Birke-Sorensen H, Bruhin A, Chariker M, Depoorter M, Dunn R, Duteille F, Ferreira F, Martinez JM, Grudzien G, Hudson D, Ichioka S, Ingemansson R, Jeffery S, Krug E, Lee C, Malmsjo M, Runkel N, International Expert Panel on Negative Pressure Wound T, Martin R, Smith J,. 2011. Evidence-based recommendations for the use of negative pressure wound therapy in chronic wounds: Steps towards an international consensus. J Tissue Viability 20 (Suppl 1): S1-18.
330. Thompson JT, Marks MW,. 2007. Negative pressure wound therapy. Clin Plast Surg 34 (4): 673-684.
331. Shweiki E, Gallagher KE,. 2013. Negative pressure wound therapy in acute, contaminated wounds: Documenting its safety and efficacy to support current global practice. Int Wound J 10 (1): 13-43.
332. Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W,. 1997. Vacuum-assisted closure: A new method for wound control and treatment: Animal studies and basic foundation. Ann Plast Surg 38 (6): 553-562.
333. Argenta LC, Morykwas MJ,. 1997. Vacuum-assisted closure: A new method for wound control and treatment: Clinical experience. Ann Plast Surg 38 (6): 563-576; discussion 577.
334. Borgquist O, Ingemansson R, Malmsjo M,. 2011. Individualizing the use of negative pressure wound therapy for optimal wound healing: A focused review of the literature. Ostomy Wound Manage 57 (4): 44-54.
335. Gupta S, Baharestani M, Baranoski S, de Leon J, Engel SJ, Mendez-Eastman S, Niezgoda JA, Pompeo MQ,. 2004. Guidelines for managing pressure ulcers with negative pressure wound therapy. Adv Skin Wound Care 17 (Suppl 2): 1-16.
336. Morykwas MJ, Argenta LC,. 1993. Use of negative-pressure to increase the rate of granulation-tissue formation in chronic open wounds. FASEB J 7 (3): A138.
337. Payne JL, Ambrosio AM,. 2009. Evaluation of an antimicrobial silver foam dressing for use with V.A.C. therapy: Morphological, mechanical, and antimicrobial properties. J Biomed Mater Res B Appl Biomater 89 (1): 217-222.
338. Nuccitelli R,. 2003. A role for endogenous electric fields in wound healing. Curr Top Dev Biol 58: 1-26.
339. Nishimura KY, Isseroff RR, Nuccitelli R,. 1996. Human keratinocytes migrate to the negative pole in direct current electric fields comparable to those measured in mammalian wounds. J Cell Sci 109 (Pt 1): 199-207.
340. Thakral G, Lafontaine J, Najafi B, Talal TK, Kim P, Lavery LA,. 2013. Electrical stimulation to accelerate wound healing. Diabet Foot Ankle 4: 10.
341. Ud-Din S, Bayat A,. 2014. Electrical stimulation and cutaneous wound healing: A review of clinical evidence. Healthcare 2: 445-467.
342. Szuminsky NJ, Albers AC, Unger P, Eddy JG,. 1994. Effect of narrow, pulsed high voltages on bacterial viability. Phys Ther 74 (7): 660-667.
343. Cutting K,. 2006. Electrical stimulation in the treatment of chronic wounds. Wounds UK 2 (1): 62-71.
344. Banerjee J, Das Ghatak P, Roy S, Khanna S, Sequin EK, Bellman K, Dickinson BC, Suri P, Subramaniam VV, Chang CJ, Sen CK,. 2014. Improvement of human keratinocyte migration by a redox active bioelectric dressing. PLoS One 9 (3): e89239.
345. Blount AL, Foster S, Rapp DA, Wilcox R,. 2012. The use of bioelectric dressings in skin graft harvest sites: A prospective case series. J Burn Care Res 33 (3): 354-357.
346. Harding AC, Gil J, Valdes J, Solis M, Davis SC,. 2012. Efficacy of a bio-electric dressing in healing deep, partial-thickness wounds using a porcine model. Ostomy Wound Manage 58 (9): 50-55.
347. Kim H, Makin I, Skiba J, Ho A, Housler G, Stojadinovic A, Izadjoo M,. 2014. Antibacterial efficacy testing of a bioelectric wound dressing against clinical wound pathogens. Open Microbiol J 8: 15-21.
348. Kim H, Izadjoo MJ,. 2015. Antibiofilm efficacy evaluation of a bioelectric dressing in mono- and multi-species biofilms. J Wound Care 24 (Suppl 2): S10-S14.
349. Aziz Z, Cullum N, Flemming K,. 2013. Electromagnetic therapy for treating venous leg ulcers. Cochrane Database Syst Rev 2: CD002933.
350. Guo L, Kubat NJ, Isenberg RA,. 2011. Pulsed radio frequency energy (PRFE) use in human medical applications. Electromagn Biol Med 30 (1): 21-45.
351. Rawe IM, Vlahovic TC,. 2012. The use of a portable, wearable form of pulsed radio frequency electromagnetic energy device for the healing of recalcitrant ulcers: A case report. Int Wound J 9 (3): 253-258.
352. Callaghan MJ, Chang EI, Seiser N, Aarabi S, Ghali S, Kinnucan ER, Simon BJ, Gurtner GC,. 2008. Pulsed electromagnetic fields accelerate normal and diabetic wound healing by increasing endogenous FGF-2 release. Plast Reconstr Surg 121 (1): 130-141.
353. Aziz Z, Cullum NA, Flemming K,. 2011. Electromagnetic therapy for treating venous leg ulcers. Cochrane Database Syst Rev (3): CD002933.
354. Farivar S, Malekshahabi T, Shiari R,. 2014. Biological effects of low level laser therapy. J Lasers Med Sci 5 (2): 58-62.
355. Chaves ME, Araujo AR, Piancastelli AC, Pinotti M,. 2014. Effects of low-power light therapy on wound healing: LASER × LED. An Bras Dermatol 89 (4): 616-623.
356. Aoki A, Mizutani K, Schwarz F, Sculean A, Yukna RA, Takasaki AA, Romanos GE, Taniguchi Y, Sasaki KM, Zeredo JL, Koshy G, Coluzzi DJ, White JM, Abiko Y, Ishikawa I, Izumi Y,. 2015. Periodontal and peri-implant wound healing following laser therapy. Periodontol 2000 68 (1): 217-269.
357. Loreti EH, Pascoal VLW, Nogueira BV, Silva IV, Pedrosa DF,. 2015. Use of laser therapy in the healing process: A literature review. Photomed Laser Surg 33 (2): 104-116.
358. Percival SL, Francolini I, Donelli G,. 2015. Low-level laser therapy as an antimicrobial and antibiofilm technology and its relevance to wound healing. Future Microbiol 10 (2): 255-272.
359. da Silva JP, da Silva MA, Almeida AP, Lombardi Junior I, Matos AP,. 2010. Laser therapy in the tissue repair process: A literature review. Photomed Laser Surg 28 (1): 17-21.
360. Beckmann KH, Meyer-Hamme G, Schroder S,. 2014. Low level laser therapy for the treatment of diabetic foot ulcers: A critical survey. Evid Based Complement Alternat Med 2014: 626127.